Effective purification of human chorionic gonadotropin and its subunits from pregnant women's urinary peptides absorbed on reverse-phase resin.
Level 5 - mechanism / opinion, no new human data
Bench research / in vitro biochemical purification study with no clinical trial data.
PubMed 2393969 · doi:10.1248/cpb.38.1414
What was done
Researchers developed and evaluated an extraction and purification method for human chorionic gonadotropin (hCG) and its subunits from pregnant women's urine. The protocol used reverse-phase resin (Sepralyte C8) adsorption followed by Sephadex G-100 gel-filtration chromatography. Bioactivity was tested using an in vitro testosterone production assay in rat Leydig cells. Near-homogeneous purified hCG was then separated into subunits using reverse-phase high-performance liquid chromatography (RP-HPLC) with an acetonitrile gradient in 0.1% trifluoroacetic acid without prior dissociation treatment, and subunit re-association was evaluated.
What was found
Approximately 15,000 IU of hCG was recovered per 1,000 ml of urine. Purified hCG stimulated rat Leydig cell testosterone production and had a specific activity of approximately 8,000 IU/mg, higher than commercial hCG preparations. RP-HPLC effectively fractionated the hormone into subunits capable of re-association.
Why it matters
This method provides a simplified, scalable chromatographic approach to extract high-potency bioactive hCG and isolate its functional subunits for research or manufacturing.
Limits
The abstract does not state the number of urine donors or batches tested, nor does it provide confidence intervals or statistical comparisons. Functional validation was restricted to an in vitro rat Leydig cell model without in vivo clinical testing.
Cited by
- supports Commercial human chorionic gonadotropin (hCG) is purified from the urine of pregnant women.